Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma. [electronic resource]
Producer: 20190322Description: e0204930 p. digitalISSN:- 1932-6203
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Benzimidazoles -- administration & dosage
- Carbamates -- administration & dosage
- Cell Line, Tumor
- Humans
- Integrin alphaVbeta3 -- metabolism
- Magnetic Resonance Imaging
- Melanoma -- diagnostic imaging
- Mice
- Mice, Nude
- Molecular Imaging
- Mutation
- Photoacoustic Techniques -- methods
- Proto-Oncogene Proteins B-raf -- genetics
- Sulfonamides -- administration & dosage
- Treatment Outcome
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.